Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 257 results for "cipla"

Big opportunities opening for Cipla
Business Standard

Big opportunities opening for Cipla

Respiratory product paves way for launch in larger markets and greater earnings visibility Ujjval Jauhari September 2, 2014 Last Updated at 21:32 IST The launch of anti-asthma metered dose inhalers (MDI) by Cipla in Germany and Sweden boosted market ... Business Standard, 2 days ago

24 images for cipla

Fast Moving, 4 days ago
Fast Moving, 5 days ago
India TV, 2 weeks ago
Money Today, 2 weeks ago, 2 weeks ago
Money Today, 2 weeks ago, 2 weeks ago
Times of India, 2 weeks ago
AME Info, 2 weeks ago
Pharma Letter, 2 weeks ago

Cipla : Teva Signs Deal for Affordable Medicines in South Africa

Medpro Pharrmaceutica, a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa , has entered into a collaboration with Teva Pharmaceuticals , an affiliate of Israel's Teva Pharmaceutical Industries Ltd. ...
 4 Traders2 days ago Cipla Medpro announces collaboration with Teva Pharmaceuticals  Individual.com1 week ago CIPLA : Teva sign pact to sell drugs in south africa  4 Traders1 week ago Cipla Medpro to market Teva's pharmaceutical products in South Africa  Pharmaceutical Technology2 weeks ago
AME Info

Cipla To Set Up Production Facility In Iran

Generic drugmaker Cipla Ltd has agreed to set up a manufacturing plant in Iran, as part of its strategy to boost its presence in the country's $4 billion pharmaceuticals market that is growing at about 13 ...
 Businessworld India2 weeks ago Indian drugmaker Cipla to launch manufacturing plant in Iran  AME Info2 weeks ago Godrej to complete acquisition of Darling Group's hair extension... Cipla signs pact to invest $37M for manufacturing unit in Iran with 75...  VC Circle2 weeks ago Cipla signs pact to invest $37M for manufacturing unit in Iran with 75...  VC Circle2 weeks ago

Cipla in agreement with Salix Pharma

Cipla has signed an agreement with Salix Pharmaceuticals, a US-based speciality pharmaceutical company. Under the agreement, Cipla has granted Salix exclusive rights under certain patent applications in the Rifaximin Complexes patent family ...
 Express Pharma2 weeks ago Cipla in the pink of health  Business Standard1 month ago Cipla gains on signing agreement with Salix Pharmaceuticals  Business Standard1 month ago Cipla, Salix Pharma sign patent out-licensing deal  Business Standard1 month ago
Business Standard

Cipla advances on tie-up with S&D Pharma

Volatility struck bourses in early trade as the key benchmark indices extended fall after staging a recovery after an initial decline. The barometer index, the S&P BSE Sensex, briefly regained positive zone. The S&P BSE Sensex was currently down 21.14 points ...
 Business Standard1 month ago Cipla launches generic version of Advair asthma drug in Germany, Sweden  Business Standard1 month ago How generic asthma drug could 'change the face of Cipla'  Money Control1 month ago Cipla hits record high  Business Standard1 month ago

Cipla: Updates on rating by Fitch Group

Cipla Ltd has informed BSE that India Ratings Research Private Limited, a Fitch Group Company have affirmed the Long-Term Issuer Rating of IND AAA to the Company and IND A1+ rating to the Company's Rs 10 billion Commercial Paper/Short Term Debt Programme.
 Money Control2 weeks ago India Ratings affirms Cipla's long-term issuer rating at 'AAA'  Indian-Commodity2 weeks ago

Midcaps, IT, pharma surge; Sensex, Nifty remain sluggish

Sun Pharma, TCS, BHEL, Infosys and Cipla are top gainers while Hindalco, HUL, Tata Power, Coal India and ITC are among the laggards in the Sensex.
 Money Control3 weeks ago Weak global cues drag Sensex by over 100 pts; SBI RIL dip  Money Control1 month ago Cautious trade drags Sensex, Nifty; Sun Pharma falls  Money Control1 month ago New closing high again: Sensex above 27000, Nifty at 8089  Money Control1 month ago
Business Standard

Cipla stock up 3%

Last week, company has announced a commercial collaboration with S&D Pharma to enter Czech Republic and Slovakia with affordable high quality alternatives Shares of Cipla Ltd was up 3% at Rs629 after on reports that Gilead Sciences plans to allow five Indian ...
 India Infoline1 month ago Cipla partners with S&D Pharma to tap Czech Republic and Slovakia  Business Standard1 month ago Cipla jumps 2%, collaborates with UK's SD Pharma  Money Control1 month ago Cipla ties up with S&D Pharma to enter Czech Republic & Slovakia  Business Standard1 month ago
Business Standard

CNX IT, CNX Pharma index down 2%

Infosys, TCS, Tech Mahindra, Wipro, HCL Tech, Aurobindo, Cipla, Dr Reddy's, Sun Pharma and Ranbaxy down 1-4% on NSE SI Reporter | Mumbai October 8, 2014 Last Updated at 10:18 IST Shares of information technology (IT) and pharmaceutical companies are under ...
 Business Standard2 weeks ago Pharma shares on roll; CNX Pharma index hits new high  Business Standard3 weeks ago Aurobindo Pharma becomes fifth most valuable pharma firm  Business Standard India2 weeks ago
Money Control

Cipla up 2%, grants exclusive license rights to Salix

Under the agreement, Cipla has granted Salix exclusive rights for certain patent applications in the ‘Rifaximin Complexes’ patent family controlled by Cipla.
 Money Control1 month ago Cipla grants Salix rights for Rifaximin  Reuters1 month ago Cipla signs license agreement with Salix  Business Standard1 month ago Cipla licenses rights for innovative product to Salix  Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less